A Study to Evaluate Zanubrutinib and Tislelizumab in Progressive Lymphoma Post CAR-T
Clinical trial NCT06167785 · RECRUITING
Trial details
- NCT number
- NCT06167785
- Sponsor
- University Health Network, Toronto
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-04
- Primary completion
- 2029-04-01
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.